Abel Hall LLC’s Genpact G Stock Holding History

Abel Hall LLC’s Portfolio G Stock Details G Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$290K	Buy	8,927 +120	+1%	+$4.06K	0.05%	453
2026 Q2	$242K	Buy	+8,807	New	+$289K	0.04%	613

Other funds holding G

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Polaris Capital Management Boston, Massachusetts $953M AUM 27.74% 1-Year Est. Return

Access Investment Management Atlanta, Georgia $412M AUM 14.18% 1-Year Est. Return

CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Crossmark Global Holdings Houston, Texas $7.69B AUM 31.68% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Sound Income Strategies Ft Lauderdale, Florida $2.24B AUM 8.38% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return

Leeward Investments Boston, Massachusetts $1.98B AUM 28.98% 1-Year Est. Return

Abel Hall LLC's G Position: Q3 2026 in Review

Abel Hall LLC increased its Genpact (G) stake by 1.4% in Q3 2026, buying an estimated $4.06K and bringing the position to 8,927 shares worth $290K. The position accounts for 0.05% of the portfolio, ranked #453.

Abel Hall LLC first reported a position in G in Q2 2026 and has held it in 2 quarters since. 113 funds tracked by Wall St. Rank hold G as of Q3 2026.

Abel Hall LLC held 8,927 shares of Genpact worth $290K as of Q3 2026.
Abel Hall LLC bought 120 Genpact shares in Q3 2026, an estimated $4.06K.
Genpact made up 0.05% of Abel Hall LLC's portfolio in Q3 2026, its #453 holding.
Abel Hall LLC first reported a position in Genpact in Q2 2026 and has held it in 2 quarters since.
113 funds tracked by Wall St. Rank held Genpact as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.